Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 HKD | +1.61% | +1.61% | +3.28% |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
Feb. 29 | Yixin Group Logs 50% Rise in Fiscal 2023 Profit | MT |
Sales 2024 * | 7.64B 1.05B 8.26B | Sales 2025 * | 8.39B 1.16B 9.07B | Capitalization | 3.8B 524M 4.11B |
---|---|---|---|---|---|
Net income 2024 * | 684M 94.4M 739M | Net income 2025 * | 819M 113M 885M | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.45 x |
P/E ratio 2024 * |
5.62
x | P/E ratio 2025 * |
4.7
x | Employees | 4,231 |
Yield 2024 * |
5.41% | Yield 2025 * |
6.45% | Free-Float | 20.71% |
Latest transcript on Yixin Group Limited
1 day | +1.61% | ||
1 week | +1.61% | ||
Current month | -4.55% | ||
1 month | -7.35% | ||
3 months | +27.27% | ||
6 months | +1.61% | ||
Current year | +3.28% |
Managers | Title | Age | Since |
---|---|---|---|
Xuan Zhang
CEO | Chief Executive Officer | 49 | 13-11-30 |
Gao Zhi
PSD | President | 53 | 16-08-31 |
Xiao Guang Yang
DFI | Director of Finance/CFO | 49 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tin Fan Yuen
BRD | Director/Board Member | 70 | 17-11-05 |
Lily Li Dong
BRD | Director/Board Member | 54 | 17-05-31 |
Xuan Zhang
CEO | Chief Executive Officer | 49 | 13-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.63 | +1.61% | 4 329 500 |
24-04-23 | 0.62 | 0.00% | 1,778,000 |
24-04-22 | 0.62 | +3.33% | 2,137,000 |
24-04-19 | 0.6 | -4.76% | 3,603,500 |
24-04-18 | 0.63 | +3.28% | 1,331,000 |
Delayed Quote Hong Kong S.E., April 24, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.28% | 516M | |
+14.51% | 4.83B | |
+1.11% | 2.57B | |
+10.92% | 2.14B | |
-2.80% | 1.15B | |
+14.16% | 770M | |
-.--% | 314M | |
+3.04% | 243M | |
+3.55% | 187M | |
+33.64% | 193M |
- Stock Market
- Equities
- 2858 Stock